E-LIB Suche - Ergebnisse für: Tafazzoli, Ali

1

Cost‐Effectiveness Analysis of Empagliflozin for Treatment ..:

Reifsnider, Odette S. ; Tafazzoli, Ali ; Linden, Stephan...
Journal of the American Heart Association. 13 (2024) 4 - p. , 2024

Link: https://doi.org/10.1161/..

2

Lifetime clinical benefits of lecanemab in early Alzheimer'..:

Monfared, Amir Abbas Tahami ; Tafazzoli, Ali ; Ye, Weicheng..
Alzheimer's & Dementia. 18 (2022) S11 - p. , 2022

Link: https://doi.org/10.1002/..

3

A European multinational cost-effectiveness analysis of emp..:

Tafazzoli, Ali ; Reifsnider, Odette S. ; Bellanca, Leana...
The European Journal of Health Economics. 24 (2022) 9 - p. 1441-1454 , 2022

Link: https://doi.org/10.1007/..

4

The Potential Value-Based Price of a Multi-Cancer Early Det..:

Tafazzoli, Ali ; Ramsey, Scott D. ; Shaul, Alissa...
PharmacoEconomics. 40 (2022) 11 - p. 1107-1117 , 2022

Link: https://doi.org/10.1007/..

5

Cost‐effectiveness models for Alzheimer's disease and relat..:

Handels, Ron L.H. ; Green, Colin ; Gustavsson, Anders...
Alzheimer's & Dementia. 19 (2022) 5 - p. 1800-1820 , 2022

Link: https://doi.org/10.1002/..

6

A Simulation Model to Evaluate the Potential Impact of Dise..:

Tahami Monfared, Amir Abbas ; Tafazzoli, Ali ; Ye, Weicheng...
Neurology and Therapy. 11 (2022) 4 - p. 1609-1623 , 2022

Link: https://doi.org/10.1007/..

7

The Potential Economic Value of Lecanemab in Patients with ..:

Tahami Monfared, Amir Abbas ; Tafazzoli, Ali ; Chavan, Ameya..
Neurology and Therapy. 11 (2022) 3 - p. 1285-1307 , 2022

Link: https://doi.org/10.1007/..

8

Long-Term Health Outcomes of Lecanemab in Patients with Ear..:

Tahami Monfared, Amir Abbas ; Tafazzoli, Ali ; Ye, Weicheng..
Neurology and Therapy. 11 (2022) 2 - p. 863-880 , 2022

Link: https://doi.org/10.1007/..

9

Efficiency Model of Cladribine Tablets Versus Infusion-Base..:

Tafazzoli, Ali ; Chavan, Ameya ; Harty, Gerard..
Advances in Therapy. 37 (2020) 9 - p. 3791-3806 , 2020

Link: https://doi.org/10.1007/..

10

P3‐296: SIMULATED COGNITIVE TRAJECTORIES IN PATIENTS WITH/W..:

Tafazzoli, Ali ; Weng, Josh ; Kansal, Anuraag R.
Alzheimer's & Dementia. 15 (2019) 7S_Part_20 - p. , 2019

Link: https://doi.org/10.1016/..

11

Alzheimer's disease Archimedes condition‐event simulator: D..:

Kansal, Anuraag R. ; Tafazzoli, Ali ; Ishak, K. Jack..
Alzheimer's & Dementia: Translational Research & Clinical Interventions. 4 (2018) 1 - p. 76-88 , 2018

Link: https://doi.org/10.1016/..

12

Capturing Latency in Cognitive Symptoms for People with Sig..:

Tafazzoli, Ali ; Kansal, Anuraag ; Weng, Josh..
Neurology. 90 (2018) 15_supplement - p. , 2018

Link: https://doi.org/10.1212/..

13

The Economic Impact of New Therapeutic Interventions on Neu..:

Tafazzoli, Ali ; Kansal, Anuraag ; Lockwood, Peter..
Dementia and Geriatric Cognitive Disorders Extra. 8 (2018) 1 - p. 158-173 , 2018

Link: https://doi.org/10.1159/..

14

[P2–559]: LONG‐TERM CLINICAL OUTCOMES WHEN SELECTIVELY TREA..:

Kansal, Anuraag R. ; Tafazzoli, Ali
Alzheimer's & Dementia. 13 (2017) 7S_Part_17 - p. , 2017

Link: https://doi.org/10.1016/..

15

A simulation study of the clinical and economic impact of d..:

Kansal, Anuraag ; Herrera-Restrepo, Oscar ; Kulkarni, Yogesh.
Neurology. 88 (2017) 16_supplement - p. , 2017

Link: https://doi.org/10.1212/..